XETRA - Delayed Quote EUR

Koninklijke Philips N.V. (PHI1.DE)

Compare
25.09
+0.21
+(0.84%)
At close: January 17 at 5:35:38 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,039,000.00
18,169,000.00
17,827,000.00
17,156,000.00
17,312,000.00
Cost of Revenue
10,430,000.00
10,721,000.00
10,633,000.00
9,988,000.00
9,493,000.00
Gross Profit
7,608,000.00
7,448,000.00
7,194,000.00
7,168,000.00
7,820,000.00
Operating Expense
7,308,000.00
7,616,000.00
7,371,000.00
6,545,000.00
6,416,000.00
Operating Income
300,000.00
-168,000.00
-177,000.00
623,000.00
1,404,000.00
Net Non Operating Interest Income Expense
-250,000.00
-266,000.00
-223,000.00
-137,000.00
-180,000.00
Other Income Expense
-135,000.00
-92,000.00
-1,332,000.00
22,000.00
-13,000.00
Pretax Income
-86,000.00
-526,000.00
-1,731,000.00
509,000.00
1,211,000.00
Tax Provision
382,000.00
-73,000.00
-113,000.00
-103,000.00
212,000.00
Net Income Common Stockholders
-328,000.00
-466,000.00
-1,608,000.00
3,319,000.00
1,187,000.00
Diluted NI Available to Com Stockholders
-328,000.00
-466,000.00
-1,608,000.00
3,319,000.00
1,187,000.00
Basic EPS
-0.33
-0.47
-1.68
3.40
1.21
Diluted EPS
-0.33
-0.47
-1.68
3.38
1.19
Basic Average Shares
979,726.25
991,199.26
952,457.44
976,933.94
980,660.08
Diluted Average Shares
979,726.25
991,199.26
952,457.44
982,749.48
990,279.55
Total Operating Income as Reported
353,000.00
-115,000.00
-1,529,000.00
553,000.00
1,264,000.00
Total Expenses
17,738,000.00
18,337,000.00
18,004,000.00
16,533,000.00
15,909,000.00
Net Income from Continuing & Discontinued Operation
-328,000.00
-466,000.00
-1,608,000.00
3,319,000.00
1,187,000.00
Normalized Income
-473,452.00
-460,980.00
-377,450.00
588,500.00
994,296.00
Interest Income
74,000.00
46,000.00
25,000.00
18,000.00
13,000.00
Interest Expense
318,000.00
306,000.00
244,000.00
164,000.00
182,000.00
Net Interest Income
-250,000.00
-266,000.00
-223,000.00
-137,000.00
-180,000.00
EBIT
232,000.00
-220,000.00
-1,487,000.00
673,000.00
1,393,000.00
EBITDA
232,000.00
1,041,000.00
115,000.00
1,996,000.00
2,855,000.00
Reconciled Cost of Revenue
10,430,000.00
10,721,000.00
10,633,000.00
9,988,000.00
9,493,000.00
Reconciled Depreciation
--
1,261,000.00
1,602,000.00
1,323,000.00
1,462,000.00
Net Income from Continuing Operation Net Minority Interest
-469,000.00
-456,000.00
-1,621,000.00
608,000.00
991,000.00
Total Unusual Items Excluding Goodwill
6,000.00
6,000.00
-1,330,000.00
26,000.00
-4,000.00
Total Unusual Items
6,000.00
6,000.00
-1,330,000.00
26,000.00
-4,000.00
Normalized EBITDA
226,000.00
1,035,000.00
1,445,000.00
1,970,000.00
2,859,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,548.00
1,020.00
-86,450.00
6,500.00
-704.00
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AAQ1.DE aap Implantate AG
1.8900
+8.62%
 
GME.DE Geratherm Medical AG
3.6800
+2.22%
 
E8X.DE elexxion AG
0.2620
+9.17%
 
SBS.DE Stratec SE
32.10
+7.00%
 
ABL.DE Abbott Laboratories
110.38
+0.91%
 
DRW3.DE Drägerwerk AG & Co. KGaA
56.10
+5.65%
 
DRW8.DE Drägerwerk AG & Co. KGaA
46.90
+3.76%
 
BSX.DE Boston Scientific Corporation
96.00
+1.05%
 
2M6.DE Medtronic plc
85.32
+2.19%
 
GETI-B.ST Getinge AB (publ)
192.70
+1.00%